Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 119.8
(-0.33%)
SAR 119.8
(-0.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 87.17 Million SAR | -16.94% |
| 2022 | 104.95 Million SAR | 35.47% |
| 2021 | 77.47 Million SAR | -13.57% |
| 2020 | 89.63 Million SAR | 88.83% |
| 2019 | 47.46 Million SAR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 91.67 Million SAR | 5.16% |
| 2024 Q2 | 99.62 Million SAR | 18.23% |
| 2023 Q4 | 87.17 Million SAR | 0.0% |
| 2023 Q1 | - SAR | -100.0% |
| 2023 Q3 | 87.17 Million SAR | -16.17% |
| 2023 Q2 | 103.99 Million SAR | 0.0% |
| 2023 FY | 91.5 Million SAR | -12.82% |
| 2022 Q3 | 100.21 Million SAR | 0.0% |
| 2022 FY | 104.95 Million SAR | 35.47% |
| 2022 Q4 | 100.21 Million SAR | 0.0% |
| 2022 Q1 | - SAR | 0.0% |
| 2021 FY | 77.47 Million SAR | -13.57% |
| 2020 FY | 89.63 Million SAR | 88.83% |
| 2019 FY | 47.46 Million SAR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 1.3 Billion SAR | 93.344% |
| Nahdi Medical Company | 1.4 Billion SAR | 93.815% |
| Al-Razi Medical Co. | 22.81 Million SAR | -282.08% |
| Almujtama Alraida Medical Co. | 143.32 Million SAR | 39.178% |